Innovent Biologics, Inc. (IVBXF)
USD 4.8
(0.0%)
USD 4.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 147.81 Million | -1.91 Billion | -2.02 Billion | -307.68 Million | -1.66 Billion | -1.01 Billion |
| Net Income | -1.14 Billion | -2.17 Billion | -3.05 Billion | -858.71 Million | -1.71 Billion | -5.87 Billion |
| Depreciation & Amortization | 385.1 Million | 319.42 Million | 204.74 Million | 85.62 Million | 86.36 Million | 64.06 Million |
| Deferred income taxes | - | -785.23 Million | 50.38 Million | 402.29 Million | -14.53 Million | -65.95 Million |
| Stock-based compensation | 574.19 Million | 469.49 Million | 501.57 Million | 402.5 Million | 153.07 Million | 53.43 Million |
| Change in working capital | 403.38 Million | 309.9 Million | -90.28 Million | -334.05 Million | -141.26 Million | 420.59 Million |
| Other non-cash items | -311.41 Million | -61.92 Million | -49.54 Million | -5.34 Million | -28.16 Million | 4.38 Billion |
| Investing Cash Flow | -998.66 Million | -1.43 Billion | -2.69 Billion | -5.18 Billion | -2.56 Billion | 859.41 Million |
| Investments in PPE | -1.38 Billion | -1.38 Billion | -1.84 Billion | -771.77 Million | -365.87 Million | -312.73 Million |
| Acquisitions | - | -361.15 Million | -630.14 Million | 88.71 Million | 70.53 Million | 178.59 Million |
| Investment purchases | -9.41 Billion | -10.32 Billion | -10.33 Billion | -11.64 Billion | -4.85 Billion | -786.47 Million |
| Sales/Maturities of investments | 9.24 Billion | 10.01 Billion | 10.12 Billion | 7.16 Billion | 2.58 Billion | 1.92 Billion |
| Other Investing Activities | 232.35 Million | 613.55 Million | -4.08 Million | -17.21 Million | -5.1 Million | -147.77 Million |
| Financing Cash Flow | 2.58 Billion | 2.89 Billion | 5 Billion | 4.91 Billion | 2.1 Billion | 4.43 Billion |
| Debt repayment | -418.49 Million | -365 Million | -255 Million | -17 Million | -10 Million | -5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 3.37 Billion |
| Common Stock Issuance | 2.25 Billion | 2.13 Billion | 3.95 Billion | 4.66 Billion | 2.17 Billion | 3.37 Billion |
| Other Financing Activities | 90.89 Million | 1.12 Billion | 1.3 Billion | 266.75 Million | -55.49 Million | -2.3 Billion |
| Accounts receivables | -430.62 Million | 393.13 Million | -493.02 Million | -225.33 Million | -242.53 Million | -7.5 Million |
| Accounts payables | - | -393.13 Million | 493.02 Million | 225.33 Million | 242.53 Million | - |
| Inventory | 358.94 Million | -105.38 Million | -641.58 Million | -311.42 Million | -292.47 Million | -8.39 Million |
| Other working capital | 566.76 Million | 415.29 Million | 551.29 Million | -22.62 Million | 151.21 Million | 428.99 Million |
| Cash at beginning of period | 1.01 Billion | 1.35 Billion | 1.27 Billion | 2.42 Billion | 4.52 Billion | 183.76 Million |
| Cash at end of period | 2.74 Billion | 1.01 Billion | 1.35 Billion | 1.27 Billion | 2.42 Billion | 4.52 Billion |
| Capital Expenditure | -1.38 Billion | -1.38 Billion | -1.84 Billion | -771.77 Million | -365.87 Million | -312.73 Million |
| Effect of forex changes on cash | -6.87 Million | 118.66 Million | -197.14 Million | -569.47 Million | 25.26 Million | 63.83 Million |
| Net cash flow / Change in cash | 1.72 Billion | -343.24 Million | 83.23 Million | -1.14 Billion | -2.09 Billion | 4.34 Billion |
| Free Cash Flow | -1.23 Billion | -3.3 Billion | -3.87 Billion | -1.07 Billion | -2.03 Billion | -1.32 Billion |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -54.47 Million | -1.14 Billion | -62.6 Million | -60.86 Million | -20.07 Million | -10.13 Million |
| Depreciation & Amortization | 27.56 Million | 385.1 Million | 8.63 Million | 8.39 Million | 27.06 Million | 13.66 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 574.19 Million | 24.45 Million | 23.77 Million | 15.64 Million | 16.52 Million |
| Change in working capital | -50.9 Million | 403.38 Million | 58.32 Million | 56.7 Million | -54.28 Million | -24.23 Million |
| Other non-cash items | 86.5 Million | -311.41 Million | 25.47 Million | 24.76 Million | 90.99 Million | -41.16 Million |
| Investing Cash Flow | -216.03 Million | -998.66 Million | -121.42 Million | -118.04 Million | 72.4 Million | 52.78 Million |
| Investments in PPE | -97.04 Million | -1.38 Billion | -36.73 Million | -35.71 Million | -90.37 Million | -43.53 Million |
| Acquisitions | 37.45 Thousand | - | -31.24 Thousand | - | 2.27 Million | - |
| Investment purchases | -743.8 Million | -9.41 Billion | -542.98 Million | - | -761.17 Million | - |
| Sales/Maturities of investments | 634.45 Million | 9.24 Billion | 348.37 Million | - | 926.91 Million | - |
| Other Investing Activities | - | 232.35 Million | -84.68 Million | -82.33 Million | -5.23 Million | 96.31 Million |
| Financing Cash Flow | -27.1 Million | 2.58 Billion | 165.02 Million | 160.42 Million | 44.36 Million | 17.81 Million |
| Debt repayment | -43.91 Million | -418.49 Million | -23.83 Million | - | -33.92 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.73 Million | 2.25 Billion | 307.29 Million | - | 2.14 Million | - |
| Other Financing Activities | 15.06 Million | 90.89 Million | 165.02 Million | 160.42 Million | 10.33 Million | 17.81 Million |
| Accounts receivables | -50.36 Million | -430.62 Million | 677.04 Thousand | 658.19 Thousand | -63.51 Million | -32.05 Million |
| Accounts payables | -21.07 Million | - | 22.3 Million | - | -15.75 Million | - |
| Inventory | 37.33 Million | 358.94 Million | 17.08 Million | 16.61 Million | 16.78 Million | 8.47 Million |
| Other working capital | -16.79 Million | 566.76 Million | 40.56 Million | 39.43 Million | 8.19 Million | -658.96 Thousand |
| Cash at beginning of period | 506.83 Million | 1.01 Billion | 303.84 Million | - | 275.6 Million | - |
| Cash at end of period | 262.24 Million | 2.74 Billion | 506.83 Million | 96.79 Million | 303.84 Million | 23.01 Million |
| Capital Expenditure | -97.04 Million | -1.38 Billion | -36.73 Million | -35.71 Million | -90.37 Million | -43.53 Million |
| Effect of forex changes on cash | - | -6.87 Million | 1.68 Million | 1.63 Million | -2.11 Million | -2.23 Million |
| Net cash flow / Change in cash | -244.59 Million | 1.72 Billion | 202.99 Million | 96.79 Million | 28.23 Million | 23.01 Million |
| Free Cash Flow | -88.35 Million | -1.23 Billion | 17.55 Million | 17.06 Million | -163.3 Million | -88.88 Million |
ZEO
DMAS
6618
3989
PREMIER
CPW